Larvol Delta - ADAPT-Forward2-ADAPT-Forward-2--ISA2--a-Study-to-Evaluate-the-Safety-Tolerability-and-Efficacy-of-Empasiprubart-IV-Monotherapy-in-Participants-With-AChRAb-Seropositive-Generalized-Myasthenia-Gravis

Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) - argenx

empasiprubart (ARGX-117) - argenx

http://clinicaltrials.gov/ct2/show/NCT07673627

Jul 25, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next